(Reuters) - Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs ...

LONDON (Reuters) - Zambia's Securities and Exchange Commission (SEC) has sanctioned Standard Chartered for mis-selling a ...

ZURICH (Reuters) -UBS could be seen as being too big for Switzerland following its takeover of Credit Suisse, former Swiss ...

As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...

(Reuters) - The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private ...

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination.

Subscribe to our daily newsletter to get investing advice, rankings and stock market news. Sign up to receive the latest updates from U.S. News & World Report and our trusted partners and sponsors.